- Home
- ATOS vs KF Comparison
ATOS vs KF Comparison
Compare ATOS & KF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- KF
- Stock Information
- Founded
- ATOS 2009
- KF 1984
- Country
- ATOS United States
- KF United States
- Employees
- ATOS N/A
- KF N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- KF Investment Managers
- Sector
- ATOS Health Care
- KF Finance
- Exchange
- ATOS Nasdaq
- KF Nasdaq
- Market Cap
- ATOS 107.2M
- KF 116.7M
- IPO Year
- ATOS 2012
- KF N/A
- Fundamental
- Price
- ATOS $0.76
- KF $27.13
- Analyst Decision
- ATOS Strong Buy
- KF
- Analyst Count
- ATOS 3
- KF 0
- Target Price
- ATOS $6.17
- KF N/A
- AVG Volume (30 Days)
- ATOS 551.3K
- KF 18.4K
- Earning Date
- ATOS 08-12-2025
- KF 01-01-0001
- Dividend Yield
- ATOS N/A
- KF N/A
- EPS Growth
- ATOS N/A
- KF N/A
- EPS
- ATOS N/A
- KF N/A
- Revenue
- ATOS N/A
- KF N/A
- Revenue This Year
- ATOS N/A
- KF N/A
- Revenue Next Year
- ATOS N/A
- KF N/A
- P/E Ratio
- ATOS N/A
- KF N/A
- Revenue Growth
- ATOS N/A
- KF N/A
- 52 Week Low
- ATOS $0.55
- KF $18.30
- 52 Week High
- ATOS $1.66
- KF $25.56
- Technical
- Relative Strength Index (RSI)
- ATOS 45.49
- KF 42.95
- Support Level
- ATOS $0.81
- KF $27.30
- Resistance Level
- ATOS $0.78
- KF $27.83
- Average True Range (ATR)
- ATOS 0.03
- KF 0.29
- MACD
- ATOS 0.00
- KF -0.10
- Stochastic Oscillator
- ATOS 50.71
- KF 14.44
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About KF Korea Fund Inc. (The) New
Korea Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek long-term capital appreciation through investment in securities, equity securities, of Korean companies. Its portfolio consists of the different sectors such as the auto components, banks, beverages, chemicals, aerospace and defense, insurance, machinery, and others.